-- 
AK Steel, Crocs, Hospira, Lennar: U.S. Equity Movers

-- B y   K a i t l y n   K i e r n a n
-- 
2011-10-20T14:59:27Z

-- http://www.bloomberg.com/news/2011-10-17/coldwater-creek-crocs-ibm-vmware-u-s-equity-preview.html
(Corrects Halozyme item in column that ran Oct. 18 to show
that Herceptin in Roche’s drug.)  Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses and prices are as of 4 p.m. in  New York .  Banks advanced after  Bank of America Corp. (BAC)  , this
year’s worst performer in the  Dow Jones Industrial Average ,
swung to a third-quarter profit on higher revenue, better  credit
quality  and one-time gains. Bank of America climbed 10 percent,
the most in the Dow average, to $6.64.  JPMorgan Chase & Co. (JPM)   rose 5.9 percent to $32.87.  Citigroup Inc. (C)   gained 7
percent to $29.88.  Wells Fargo & Co. (WFC)   advanced 5.9
percent to $25.86.  Morgan Stanley (MS)   jumped 9.1 percent to
$16.63.  State Street Corp. (STT)   increased 11 percent to $37.49.
The custody bank under pressure from activist investor  Nelson
Peltz  to increase profitability said third-quarter profit rose
11 percent, helped by cost-cutting and a takeover.  U.S. homebuilders rose after an index of developer
sentiment increased to its highest level since May 2010. D.R.
Horton Inc. (DHI US) gained 11 percent to 10.59.  Pulte Group
Inc. (PHM)   jumped 11 percent to $4.46.  Lennar Corp. (LEN)  
rose 9.3 percent to $15.92.  Active Power Inc. (ACPW)   slid 17 percent, the most since
July 27, to $1.18. The maker of backup mechanical batteries said
Chief Executive Officer Jim Clishem resigned to pursue other
interests. Jan Lindelow, a company director, was appointed as
the interim CEO, Active Power said.  AK Steel Holding Corp. (AKS)   jumped 13 percent, the most
in the  S&P 500 , to $8.06. The third-largest U.S. steelmaker by
sales was raised to “neutral” from “sell” at  Goldman Sachs
Group Inc. (GS) , which said that recently announced investments its
supply chain will improve investor perceptions of the company.  American Public Education Inc. (APEI)   dropped 18
percent, the most since Aug. 6, to $31.01. The operator of the
American Military University slipped after the U.S. Marine Corps
cut tuition assistance for service members who take classes
during off-duty time by 75 percent.  Badger Meter Inc. (BMI)   fell 13 percent, the most since
March 2009, to $29. The maker of water meters and fluid-control
devices reported third quarter earnings of 46 cents per share,
missing the average analyst estimate by 16 percent, according to
Bloomberg data. The Milwaukee-based company was cut to
“neutral” from “buy” at Janney Montgomery Scott.  Crocs Inc. (CROX)   plunged 39 percent to $16.15 for the
biggest retreat in the Russell 2000 Index. The plastic-clogs
maker cut its third-quarter earnings-per-share estimate to lower
than the average of analysts surveyed by Bloomberg, citing
“softness” in the consumer direct channel kiosk and outlet
locations.  DaVita Inc. (DVA)   climbed 6.1 percent, the most since
July 26, to $65.39. The operator of kidney dialysis centers said
it earned at least $1.43 a share from continuing operations in
the third quarter. Analysts, on average, estimated $1.32 a share
excluding some items, according to a Bloomberg survey.  Fortune Brands Home & Security Inc. (FBHS US) rallied 5.5
percent to $14.48, the highest price since it was spun off from
Fortune Brands Inc. this month.  Bill Ackman , who runs Pershing
Square Asset Management, recommended buying the stock at the
Value Investing Congress in New York.  Halozyme Therapeutics Inc. (HALO)   rallied 19 percent,
the most since March 2010, to $7.35. The San Diego-based
biopharmaceutical company reported an investigational
subcutaneous injection of Herceptin,  Roche Holding AG ’s breast
cancer drug, using Halozyme’s technology, produced comparable
results to Herceptin given as an intravenous infusion. The
drugmaker was boosted to “market outperform” from “market
perform” by JMP Securities.  Harley-Davidson Inc. (HOG)   slid 7 percent, the most
since Aug. 18, to $34.59. The biggest U.S. motorcycle maker
reported sales of $1.23 billion, missing the average of 13
analysts’ estimates by 4 percent, and narrowed its full-year
gross margin forecast to at most 34.5 percent from as high as 35
percent.  Hospira Inc. (HSP)   fell the most in the Standard &
Poor’s 500 Index, plunging 21 percent to $29.51. The maker of
generic injectable drugs reduced its annual earnings estimate
because of its response to a warning letter from the U.S. Food
and Drug Administration last year and subsequent observations at
a North Carolina factory.  Human Genome Sciences Inc. (HGSI)   rose 14 percent, the -
most in the Russell 1000 Index, to $12.82. GlaxoSmithKline Plc
(GSK LN), the U.K.’s largest drugmaker, may make a $25 a share
cash offer for Rockville, Maryland-based drugmaker Human Genome
Sciences, the U.K’s Daily Mail reported, citing market
speculation.  Ingram Micro Inc. (IM)   declined 7.2 percent, the most
since April 29, to $17.38. The distributor of information-
technology products said it earned 34 cents a share at most in
the third quarter, below the average analyst estimate of 41
cents a share.  International Business Machines Corp. (IBM)   fell the
most in the Dow Jones Industrial Average, dropping 4.1 percent
to $178.90. The biggest computer-services company reported
third-quarter sales that missed analysts’ estimates on slowing
revenue growth at its software, hardware and services
businesses.  New World Development Co. (NDVLY US) plunged 17 percent to
$1.85 for the biggest decline since September 2008. The Hong
Kong real estate company said it plans to raise HK$12.3 billion
($1.6 billion) selling stock at a discount to fund property
projects and boost capital.  STR Holdings Inc. (STRI)   fell 9.6 percent, the most
since Aug. 4, to $7.85. The solar-panel parts maker withdrew its
2011 financial forecast, citing a lack of clarity on global
demand.  Taro Pharmaceutical Industries Ltd. (TAROF US) rallied 23
percent, the most since January 1999, to $24.  Sun Pharmaceutical
Industries Ltd. (SUNP)  , which owns a 66.3 percent stake in
the Israeli drugmaker, offered to buy the outstanding stock for
$24.50 a share, according to a regulatory filing.  Uranium Resources Inc. (URRE)   climbed 19 percent to 92
cents, the second-biggest gain in the Russell 2000 Index. The
uranium miner’s license to produce 3 million pounds of the
nuclear fuel in  New Mexico  was reactivated by the  Nuclear
Regulatory Commission .  To contact the reporter on this story:
Kaitlyn Kiernan in New York at 
 kkiernan2@bloomberg.net   To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  